Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

634.75
Delayed Data
As of Dec 02
 +4.16 / +0.66%
Today’s Change
441.00
Today|||52-Week Range
686.62
+31.39%
Year-to-Date

Stock Price Forecast

The 21 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 700.00, with a high estimate of 850.00 and a low estimate of 565.00. The median estimate represents a +10.28% increase from the last price of 634.75.

Analyst Recommendations

The current consensus among 24 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$18.90
Sales
$4.3B
Reporting Date
Feb 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 22.94%
 
 
 
 
 
 
Growthannually 123.58%
 
 
 
 
 
 

Sales

Growthquarterly 25.28%
 
 
 
 
 
 
Growthannually 81.79%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.